Introduction
Congenital deafness is an irreversible condition due to intrauterine dysplasia or genetic factors. An estimated 30,000 babies are born with congenital hearing impairment per 20 million live births every year in China, and this impairment seriously affects their quality of life. Worldwide, the incidence of congenital deafness, including deafness caused by many genetic and environmental factors, is about 1/1000 (1) . An estimated 80,000 new patients appear each year because of the clinical use of a large number of antibiotics. People with disabilities in Hebei number about 519.5 million, accounting for 1.86% of the province's population. People with disabilities include 126.0 million with a hearing disability and 7.7 million with a speech disability, and these 2 types of disabilities account for 25.74% of all disabilities.
Gap junction protein beta-2 (GJB2) (MIM 220290) was the first gene in which mutations were reported to cause autosomal recessive nonsyndromic hearing loss (ARNSHL) in 1997 (2) . Although mutations in GJB3 (MIM 603324) and GJB6 (MIM604418) were subsequently discovered, GJB2 remains the most common cause of hereditary deafness in many populations. Mutations in GJB2 were discovered and were shown to cause up to 50% of ARNSHL in Caucasian populations, but their frequency is much lower in other parts of the world (3-5). The c.235delC mutation is the most frequent pathogenic variant in Japanese (6) , while the c.35delG mutation is the most frequent pathogenic variant in the majority of Caucasian populations (70%) (7) , and the c.167delT mutation is the most common in Ashkenazi Jews (8) . Indeed, mutations in other connexin genes, such as GJB6 for Cx30 and GJB3 for Cx31, have been identified and shown to cause hearing impairment (9, 10) .
The SLC26A4 gene encodes pendrin, which is a transmembrane anion exchanger that belongs to the solute carrier 26 family and that exchanges chloride, iodide, bicarbonate, and formate. Pendrin is expressed in different tissues, including the thyroid, the kidneys, and the inner ear. In the cochlea, pendrin is found in the apical membrane of the outer sulcus and spiral prominence epithelial cells that border the endolymph, in the spiral ganglion, and in supporting cells (11) . DNA sequencing has identified more than 100 different mutations in SLC26A4 (12) (13) (14) (15) . SLC26A4 mutations may account for as much as 10% of the hereditary deafness in diverse populations (16) . Four of these mutations, IVS7-2A>G, 2168A>G, 84C>A, 1975G>C, 754 T>C, and IVS 9+1G>A, were previously reported in patients with hearing loss (17) (18) (19) , and IVS7-2A >G is the most prevalent mutation in China (20) .
Although most cases of hereditary hearing loss are caused by nuclear gene defects, a study has shown that mutations in mitochondrial DNA (mtDNA) can also cause nonsyndromic hearing loss (21, 22) . The 1555A>G mutation is the best studied of these mutations in the mitochondrial 12S rRNA gene. The second mutation identified in the mitochondrial 12S rRNA gene is the 1494C>T in the conserved stem structure of 12SrRNA (23) . Other nucleotide changes at positions 961 and 1095 in the 12S rRNA gene have been shown to be associated with hearing loss, but their pathogenic mechanisms of action in the predisposition of carriers to aminoglycoside toxicity are much less clear (24, 25) . The mtDNA 1555A>G mutation accounts for a small fraction of nonsyndromic hearing loss, with a prevalence of 3.43% in China, 3% in Japan, and 3.43% in Indonesia (26) (27) (28) ; this mutation is less evident in Caucasian populations, with a prevalence between 0.6% and 2.5% (29) (30) (31) .
The present study comprehensively analyzed 4 prominent deafness-related genes, GJB2, GJB3, SLC26A4, and mtDNA 12SrRNA, in 318 students at schools for the deaf or special needs schools and their parents in 9 cities in Hebei Province, China.
Subjects and Methods
Potential subjects were students at schools for the deaf or special needs schools in 9 cities in Hebei Province. Subjects were 318 students with non-syndromic deafness (with 30-48 subjects per city). Subjects consisted of 64 males and 154 females ranging in age from 2 months to 58 years, with an average age of 10.48 years. Once parental consent was obtained, 15 families were studied ( Figure 1 ). After subjects and their guardians agreed to voluntarily participate in genetic testing, they provided informed consent in writing. Subjects were asked to provide basic personal information, including marriage information, family history, pregnancy history, gestation history, medication history, history of infection, whether abnormalities occurred during pregnancy, whether birth gene mutations were detected in 2 (0.63%). No GJB3 mutations were detected. A homozygous mutation was detected in 40 students (12.58%). A homozygous mutation in GJB2 was detected in 16 students (5.03%), a homozygous mutation in SLC26A4 was detected in 22 (6.92%), and a homogeneous mutation in mtDNA 12rRNA was detected in 2 (0.63%). Heterozygous mutations were detected in 97 students (30.50%). Heterozygous mutations in GJB2 were detected in 38 students (11.95%), heterozygous mutations in SLC26A4 were detected in 59 (18.55%) ( Table 1) , compound heterozygous mutations were detected in 23 (7.23%), and double heterozygous mutations were detected in 23 (7.23%). A compound heterozygous mutation was detected in 19 students (GJB2 in 11 students and SLC26A4 in 8 students) (5.97%), and a double heterozygous mutation was detected in 3 (1.26%) ( Tables 2 and 3) .
Heterozygous mutations in the form of exon was premature, whether the neonate had a low birth weight, whether there was an obvious history of head injury before deafness, the use of ototoxic drugs, and detailed medical records. Specimens were then collected. Three to 5 mL of peripheral blood was collected with a vacuum blood collection tube. Specimens were numbered and blood was dropped on filter paper. DNA was extracted from 2 specimens per subject. UV spectrophotometry was used to quantify and test the purity of the specimen. Specimens were recorded and stored separately by city. Nine gene loci -GJB2 35delG, 176del16, 235delC, 299-300delAT, GJB3 538, SLC26A4 2168A>G, and IVS7-2A>G, 12SrRNA 1494C>T, and 1555A>G -were detected in 4 common genes (GJB2, GJB3, SLC26A4, and mtDNA 12SrRNA) using the GeneChip (Beijing Boao Bio Co., Ltd.). Twenty other gene loci -GJB2 167delT, GJB3 547G>A, SLC26A4 281C>T, 589G>A, 1174A>T, 1226 G>A, 1229C>T, IVS15+5 G>A, 1975G>C, 2027T>A, and 2162C>T -were detected with time-of-flight mass spectrometry. Fourteen gene loci -GJB2 35delG, 176del16, 235delC, 299-300delAT, 155delTCTG, 512insAACG, SLC26A4 2168A>G, IVS7-2A>G 1229C>T, and 1174A>T, GJB3 538C>G, 547G>A, 12SrRNA 1494C>T, and 1555A>G -in the 4 genes were analyzed in 36 of the 318 students using fluorescence quantitative PCR (Jinan Yingsheng Biology). Exons of GJB2 were analyzed in 3 students using gene sequencing.
All of the members of 15 families underwent acoustic immittance testing, and 13 of the 20 family members with mutations or variants in SLC26A4 underwent a temporal bone computed tomography (CT) scan for diagnosis of enlarged vestibular aqueducts or inner ear malformation.
Results
Gene mutations were detected in 137 (43.08%) of 318 students. GJB2 mutations were detected in 54 students (16.98%), SLC26A4 gene mutations were detected in 81 (25.47%), and mitochondrial 12SrRNA No. students 2 1
Mutation polymorphisms in the GJB2 gene were detected in 36 students. Gene sequencing indicated that 26 students had mosaic or compound heterozygous mutations (66.67%), with 1 student exhibiting a 79G>A homozygous mutation and 1 exhibiting a heterozygous mutation in the form of 341A>G polymorphism. A 79G>A homozygous mutation was detected in 5 students (13.89%), a 608T>C heterozygous mutation was detected in 4 (11.11%), and a complex polymorphic mutation was detected in 15 (41.67%) ( Table 4) . A family study found that the proband's parents had normal hearing in 15 pedigrees (Table 5 ). Pedigrees 1, 2, and 14 exhibited GJB2 mutations, with pedigree 2 exhibiting a heterozygous mutation in GJB2 and pedigrees 1 and 14 exhibiting a compound heterozygous mutation in GJB2. These 3 pedigrees accounted for 20% of the 15 pedigrees. SLC26A4 gene mutations were found in 9 pedigrees: 3, 6, 7, 8, 9, 10, 11, 12, and 13 (including pedigrees 6, 7, 8, 9, and 13 with a homozygous mutation and pedigrees 3, 10, 11, and 12 with a heterozygous mutation). These 9 pedigrees accounted for 4.5% of 60 pedigrees in total. Pedigrees with a double GJB2/SLC26A4 heterozygous mutation (including a GJB2/235delC homozygous mutation in pedigree 5 and a double heterozygous SLC2/6A4 mutation and double heterozygous mutations of GJB2 235delC and IVS7-2 A>G in pedigree 4) accounted for 13.33% of the pedigrees. Pedigree 15 had a SLC26A4 1229C>T and 2168A>G compound heterozygous mutation.
Discussion
Congenital deafness is one of the most common birth defects in humans, with an incidence of about 1 ‰ to 3 ‰ (32). This condition seriously affects an individual's quality of life. About 50-60% of these cases have a genetic cause. The cause is an autosomal recessive condition in 80% and an autosomal dominant condition in 10% to 20%. These conditions are sexlinked at a rate between 1% and 2%. Thus far, at least 44 deafness-related genes have been identified. The most common gene is GJB2, which is located in 13q11-12. In 1998, Xia et al. (33) first reported GJB3, a gene located in 1p33-35. A mutation in SLC26A4, which is located in q22-31.1, has been found to be associated with large vestibular conduit syndrome. A mutation in 12SrRNA in mtDNA has been proven to be associated with drug-induced deafness. At present, strategies to prevent deafness universally include newborn hearing screening, which is one of the keys to the early detection and diagnosis of hearing impairment (34) , and these strategies have achieved remarkable developments. Although genetic testing enables an estimation of the chance of reoccurrence, there are many other reasons why children with congenital hearing loss should undergo genetic evaluation and receive genetic counseling (32) . Providers of genetic testing and counseling services have an important role to play in reducing hearing loss in newborns and young children.
Genetic screening detected mutations in 137 (43.08%) of 318 students. Genetic mutations were identified in 13 of 51 deaf children (25.49%) in Qianghu, Anhui (35) . Gene mutations at 9 sites of 4 genes, including GJB2, GJB3, SLC26A4, and 12SrRNA, were found in a total of 22 (34.4%) of 64 patients with nonsyndromic hearing impairment in Henan (36) . Furthermore, patients in Shanxi and Liaoning provinces tested positive for mutations in SLC26A4, GJB2, or 12SrRNA 1555 A>G/1494C>T at a rate of 33.3% and 42.5%, respectively (37, 38) . Thus, research has shown that the rate of mutations in deafness genes is higher in Hebei than in other regions. In the current study, mutations in SLC26A4 were identified in 25.47% of students (81/318) with hearing impairment in Hebei of China. Thirty of the 81 students had 2 mutant alleles while 51 had 1 mutant allele. The most common mutation was IVS7-2A>G. The spectrum of SLC26A4 mutations in Hebei is similar to that reported in the overall Chinese population, with IVS7-2A>G being a hotspot mutation. In Japan, H723R is the most prevalent mutation (16) . In South Korea, IVS7-2A>G and H723R are the two most prevalent (39) . A recent study of 109 unrelated probands with enlarged vestibular aqueducts in a Danish population found that the most frequent mutation was 1246A>C. This implies that Danish and Chinese populations are of different ancestry (40) . In the current study, GJB2 gene mutations were detected in 54 students (16.98%). 35delG is most common mutation in Caucasians. Yuan et al. (41) reported that 235delC accounted for 71.64% of GJB2 mutant alleles in China, and this figure agrees with the findings of the current study (71.43%, 50/70 students). This mutation is detected at the highest rates in Asian populations, with a prevalence of approximately 41% and 57% (41) (42) (43) (44) (45) (46) . 12SrRNA mutations were detected in 2 students (0.63%), although this rate is lower than their prevalence nationally (2.83%) (47) . No GJB3 mutations were noted in students. Studies have shown that the SLC26A4 gene, the GJB2 gene, and the mitochondrial 12SrRNA gene are prominent mutations that lead to most of the hereditary deafness in Asia. Screening for mutations in these 3 genes is crucial to identifying nonsyndromic hereditary hearing loss and drug-induced deafness. The current study identified 15 pedigrees of mutations. Genetic testing can provide a scientific basis for guiding and advising deaf patients and their family members. One example is the members of pedigree 4. Two individuals were lovers who sought consultation before marriage (48) . The first question they asked was whether they could get married. The second question was whether their child would be deaf like them. They consented to undergo genetic testing. The woman's test results were negative for mutations while the man's GJB2 genetic testing revealed double heterozygous mutations of 235delc and SLC26A4 IVS7-2 A>G. Given a scientific estimate regarding the potential for them to have a hearing child, they decided to marry and gave birth to a baby girl with normal hearing. When the gene chip was used to detect 9 loci of 4 genes, it only found GJB2 and SLC26A4 gene mutations, but subsequent timeof-flight mass spectrometry found 20 mutations (4 gene loci) in 11 students (3.46%). The SLC26A4 gene mutation of 1226 G> A was detected in 3 students, the gene mutation of 1229 C>T was detected in 7, and the gene mutation of 2027 T>A was detected in 1. Genetic information can provide more comprehensive information for genetic counseling. Thus, this study suggests that high-risk families should choose 2 methods of genetic testing to avoid a false negative for mutations.
This study detected polymorphisms of the GJB2 gene. Four polymorphisms were detected in 36 students, including heterozygous mutations in 109 G>A in 1 (2.78%) and in 79 G>A in 22 (61.11%). Homozygous mutations were detected in 1 student. Heterozygous and homozygous mutations in 341A>G were detected in 14 students (38.89%). A heterozygous mutation in 608 T>C was detected in 4 students (11.11%). A study by Liu et al. (49) found that 79G>A, 341A>G, 109G>A, and 608T>C were common polymorphisms in the Dai and Han ethnic groups. A study by Li et al. (50) detected GJB2 mutations in neonates and identified the 4 types of mutation they considered to be polymorphisms. Other studies have shown that 79G>A, 341A>G, and 608T>C are found in the general population but do not cause deafness (51) (52) (53) . The current study found that these changes are common GJB2 gene polymorphisms. A change in genetic polymorphism means that the structure of DNA molecules changes in an individual in a population, but the aspects of gene expression and gene function remain the same. A change in polymorphism is a normal phenomenon, spontaneously occurring at a rate of around 1% (54) . Currently, the 109 G>A mutation is assumed to be a mutation resulting in substitution of G for A. A point mutation will result in substitution of the encoded amino acid (valine replaced with isoleucine). However, the issue of whether a mutation substituting G for A at locus 109 of the GJB2 gene can directly lead to hereditary deafness remains controversial in domestic and foreign literature. Kelly et al. (55) has detected the 109 G>A mutation in normal populations, implying that the polymorphic change does not lead directly to hereditary deafness. However, a study by Abe et al. (45) in Japan reached the opposite conclusion. There is no clear consensus in academic circles on whether a mutation at a specific locus leads to hereditary deafness. Thus, whether the 109 G>A mutation in GJB2 leads to deafness must be studied further.
Hereditary deafness is a common form of severe hearing loss. Genetic testing is a useful way to dispel misinformation or alleviate concerns that parents have about what may have caused hearing loss. Although gene screening plays an important role in decreasing the birth rate of deaf infants, many problems still need to be solved, such as the widespread shortage of technical personnel in genetic testing laboratories. Another problem is the lack of guidelines indicating whether genetic testing for deafness should be performed prior to marriage, prior to pregnancy, prior to birth, or after birth. The lack of solutions constrains the development of methods of genetic screening for deafness. Under current conditions, genetic screening still has a long way to go to facilitate the detection of deafness genes. In other words, the development of prenatal diagnosis and genetic counseling will greatly reduce the birth rate of deaf children, decrease the number of deaf patients, improve the quality of births, and reduce the social and family burden of deafness.
